Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment

被引:50
作者
Fass, Ronnie
机构
[1] So Arizona VA Hlth Care Syst, Neuroenter Clin Res Grp, GI Sect, Tucson, AZ 85723 USA
[2] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
关键词
gastroesophageal reflux disease (GERD); heartburn; quality of life; proton pump inhibitors;
D O I
10.1097/MCG.0b013e31802e849f
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Relief of symptoms, both typical and atypical, is the mainstay of therapy for patients with gastroesophageal reflux disease (GERD); however, evaluation of GERD symptoms' response to treatment has been hampered by the lack of a questionnaire that meets all the criteria of an ideal evaluative GERD symptom assessment tool. These criteria are: sensitivity in GERD patients, covering all symptom dimensions (multidimensional construct), assessment of frequency and intensity of '' typical '' and '' atypical '' GERD symptoms, practical and economical, easy to understand, responsive over short time intervals, use as a patient self-assessment tool, amenable to daily use, psychometrically validated, and translation into many languages with cross-cultural adaptation. Thus far, 14 instruments have been developed to assess GERD symptoms and potentially can be used to evaluate treatment response during a therapeutic trial in GERD patients. However, comparison of the different evaluative tools is needed.
引用
收藏
页码:437 / 444
页数:8
相关论文
共 61 条
[1]   Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease [J].
Allen, CJ ;
Parameswaran, K ;
Belda, J ;
Anvari, M .
DISEASES OF THE ESOPHAGUS, 2000, 13 (04) :265-270
[2]   Changing impact of gastroesophageal reflux in medical and otolaryngology practice [J].
Altman, KW ;
Stephens, RM ;
Lyttle, CS ;
Weiss, KB .
LARYNGOSCOPE, 2005, 115 (07) :1145-1153
[3]   Validation of the short-form REFLUX-QUAL® (RQS®), a gastro-esophageal reflux disease (GERD) specific quality of life questionnaire [J].
Amouretti, M ;
Nalet, B ;
Robaszkiewicz, M ;
Wainsten, JP ;
de la Loge, C ;
Benmedjahed, K ;
Dias-Barbosa, C ;
Brin, S ;
Schatz, B .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2005, 29 (8-9) :793-801
[4]   Validation of a short questionnaire in English and French for use in patients with persistent upper gastrointestinal symptoms despite proton pump inhibitor therapy: The PASS (Proton pump inhibitor Acid Suppression Symptom) test [J].
Armstrong, D ;
van Zanten, SJOV ;
Chung, SA ;
Shapiro, CM ;
Dhillon, S ;
Escobedo, S ;
Chakraborty, BK ;
Mann, V ;
Tanser, L ;
Nevin, K .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2005, 19 (06) :350-358
[5]   The construction of a new evaluative GERD questionnaire -: Methods and state of the art [J].
Armstrong, D ;
Mönnikes, H ;
Bardhan, KD ;
Stanghellini, V .
DIGESTION, 2004, 70 (02) :71-78
[6]  
BARDHAN K, 2005, CAN J GASTROENTER SC, V19
[7]   International validation of ReQuest in patients with endoscopy-negative gastro-oesophageal reflux disease [J].
Bardhan, KD ;
Stanghellini, V ;
Armstrong, D ;
Berghöfer, P ;
Gatz, G ;
Mönnikes, H .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (08) :891-898
[8]   Evaluation of GERD symptoms during therapy -: Part I.: Development of the new GERD questionnaire ReQuest™ [J].
Bardhan, KD ;
Stanghellini, V ;
Armstrong, D ;
Berghöfer, P ;
Gatz, G ;
Mönnikes, H .
DIGESTION, 2004, 69 (04) :229-237
[9]   Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: Results of the US upper gastrointestinal study [J].
Camilleri, M ;
Dubois, D ;
Coulie, B ;
Jones, M ;
Kahrilas, PJ ;
Rentz, AM ;
Sonnenberg, A ;
Stanghellini, V ;
Stewart, WF ;
Tack, J ;
Talley, NJ ;
Whitehead, W ;
Revicki, DA .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2005, 3 (06) :543-552
[10]   Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease [J].
Coyne, KS ;
Wiklund, I ;
Schmier, J ;
Halling, K ;
Degl'Innocenti, A ;
Revicki, D .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (09) :907-915